enrofloxacin has been researched along with Infections, Pseudomonas in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (50.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ghorbani, G; Rahimi, E; Shakerian, A | 1 |
| Baxter, CG; Vogelnest, LJ | 1 |
| Kawamoto, E; Kunita, S; Sasaki, H; Yagami, K | 1 |
| Moss, SM; Rees, R; See, AM; Trott, DJ | 1 |
| Batt, RM; Elwood, CM; Rutgers, HC; Simpson, KW; Stepien, RL | 1 |
| Anderson, MA; Branson, KR; Mann, FA; Pope, ER | 1 |
| Ferguson, JF | 1 |
| Farca, AM; Maffei, F; Piromalli, G; Re, G | 1 |
8 other study(ies) available for enrofloxacin and Infections, Pseudomonas
| Article | Year |
|---|---|
Antibiotic resistance's Genotypic and Phenotypic Characteristics and the Frequency of Virulence Factors in
Topics: Anti-Bacterial Agents; Chloramphenicol; Drinking Water; Enrofloxacin; Erythromycin; Gentamicins; Humans; Imipenem; Iran; Meropenem; Microbial Sensitivity Tests; Mineral Waters; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence Factors | 2022 |
Multifocal papular deep bacterial pyoderma in a Boxer dog caused by Pseudomonas aeruginosa.
Topics: Animals; Anti-Bacterial Agents; Cyclosporine; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Immunohistochemistry; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Pyoderma; Treatment Outcome | 2008 |
Comparison of the in vitro susceptibility of rodent isolates of Pseudomonas aeruginosa and Pasteurella pneumotropica to enrofloxacin.
Topics: Animals; Anti-Bacterial Agents; Enrofloxacin; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Mutation; Pasteurella Infections; Pasteurella pneumotropica; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rodent Diseases | 2007 |
Evaluation of disc diffusion and MIC testing for determining susceptibility of Pseudomonas aeruginosa isolates to topical enrofloxacin/silver sulfadiazine.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Therapy, Combination; Enrofloxacin; Fluoroquinolones; Otitis Media; Pseudomonas aeruginosa; Pseudomonas Infections; Silver Sulfadiazine | 2007 |
Enrofloxacin treatment of gram-negative infections.
Topics: Animals; Anti-Infective Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Gram-Negative Bacterial Infections; Pseudomonas Infections; Quinolones; Salmonella Infections, Animal | 1994 |
Use of an ultrasonic Doppler flow detector for determining tissue viability in a dog.
Topics: Animals; Anti-Infective Agents; Arteries; Bone Wires; Cefadroxil; Dogs; Enrofloxacin; Female; Fluoroquinolones; Forelimb; Fractures, Bone; Pseudomonas Infections; Quinolones; Regional Blood Flow; Staphylococcal Infections; Tissue Survival; Toes; Ultrasonography, Doppler; Wound Infection | 1994 |
What is your diagnosis?. Infected fracture with secondary osteomyelitis.
Topics: Animals; Anti-Infective Agents; Bone Plates; Bone Transplantation; Dog Diseases; Dogs; Enrofloxacin; Fluoroquinolones; Fracture Fixation, Intramedullary; Osteomyelitis; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Radiography; Tibial Fractures; Wound Infection | 1995 |
Potentiating effect of EDTA-Tris on the activity of antibiotics against resistant bacteria associated with otitis, dermatitis and cystitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Buffers; Cephaloridine; Cephalosporins; Cystitis; Dermatitis; Dog Diseases; Dogs; Drug Synergism; Edetic Acid; Enrofloxacin; Escherichia coli Infections; Female; Fluoroquinolones; Kanamycin; Male; Otitis; Proteus Infections; Proteus mirabilis; Pseudomonas Infections; Quinolones; Staphylococcal Infections; Time Factors; Tromethamine | 1997 |